These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25669997)

  • 21. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome.
    Nectoux J; Bahi-Buisson N; Guellec I; Coste J; De Roux N; Rosas H; Tardieu M; Chelly J; Bienvenu T
    Neurology; 2008 May; 70(22 Pt 2):2145-51. PubMed ID: 18434641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-derived neurotrophic factor and Rett syndrome.
    Katz DM
    Handb Exp Pharmacol; 2014; 220():481-95. PubMed ID: 24668484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
    Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
    Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
    Nag N; Mellott TJ; Berger-Sweeney JE
    Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MECP2 mutations in Serbian Rett syndrome patients.
    Djarmati A; Dobricić V; Kecmanović M; Marsh P; Jancić-Stefanović J; Klein C; Djurić M; Romac S
    Acta Neurol Scand; 2007 Dec; 116(6):413-9. PubMed ID: 17986102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome.
    Lioy DT; Wu WW; Bissonnette JM
    Auton Neurosci; 2011 Apr; 161(1-2):55-62. PubMed ID: 21316312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
    Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.
    Tsai SJ
    Med Hypotheses; 2007; 68(5):1144-6. PubMed ID: 16996699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rett syndrome: clinical and molecular aspects].
    Záhoráková D; Zeman J; Martásek P
    Cas Lek Cesk; 2007; 146(8):647-52. PubMed ID: 17874730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
    Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
    Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
    Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
    Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skewed X chromosome inactivation failed to explain the normal phenotype of a carrier female with MECP2 mutation resulting in Rett syndrome.
    Takahashi S; Ohinata J; Makita Y; Suzuki N; Araki A; Sasaki A; Murono K; Tanaka H; Fujieda K
    Clin Genet; 2008 Mar; 73(3):257-61. PubMed ID: 18190595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M; Zoghbi HY
    Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Potential Life-Threatening Reaction to Glatiramer Acetate in Rett Syndrome.
    Nissenkorn A; Kidon M; Ben-Zeev B
    Pediatr Neurol; 2017 Mar; 68():40-43. PubMed ID: 28254244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical features in MECP2 P152R-associated Rett syndrome.
    Sheen V; Valencia IM; Torres AR
    Pediatr Neurol; 2013 Aug; 49(2):124-6. PubMed ID: 23859859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome.
    Lintas C; Sacco R; Persico AM
    Neurobiol Dis; 2012 Jan; 45(1):57-68. PubMed ID: 21130877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loud and clear evidence for gene silencing by epigenetic mechanisms in autism spectrum and related neurodevelopmental disorders.
    Lopez-Rangel E; Lewis ME
    Clin Genet; 2006 Jan; 69(1):21-2. PubMed ID: 16451129
    [No Abstract]   [Full Text] [Related]  

  • 39. Somatic mosaicism for Y120X mutation in the MECP2 gene causes atypical Rett syndrome in a male.
    Pieras JI; Muñoz-Cabello B; Borrego S; Marcos I; Sanchez J; Madruga M; Antiñolo G
    Brain Dev; 2011 Aug; 33(7):608-11. PubMed ID: 20970936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits.
    Schaevitz LR; Gómez NB; Zhen DP; Berger-Sweeney JE
    Genes Brain Behav; 2013 Oct; 12(7):732-40. PubMed ID: 24283265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.